Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

The pandemic highlighted the need for accurate information, vaccine development, and adapting to new routines while managing stress and misinformation.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

A global, inclusive approach is needed to address COVID-19 and protect vulnerable groups.

Possible link between COVID-19 and hair loss; more research needed.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Awareness of Penile Thread Tourniquet Syndrome is crucial for preventing severe complications in children.

Collider bias can distort our understanding of COVID-19 risk and severity.

The guideline offers practical advice for diagnosing and treating Post-COVID/Long-COVID.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

Nanozymes greatly improve biocatalysis by being stable, efficient, and versatile.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Using fat stem cells and blood cell-rich plasma together improves healing in diabetic wounds by affecting cell signaling.